Umberto Basso
Papers
2
Total Citations
11
H-Index
2
About
Umberto Basso is a leading figure in urologic oncology, with a research focus that bridges surgical innovation and complex cancer management. His work is particularly distinguished by pioneering efforts in the treatment of rare adult malignancies, most notably adult Wilms’ tumor. In a landmark 2022 feasibility study, Basso demonstrated the safe application of a robotic surgical approach combined with neoadjuvant chemotherapy for this exceedingly rare condition—a population where adult cases account for less than 1% of kidney cancers and carry a significantly worse prognosis than in children. This contribution, which includes a systematic review of the literature, has already garnered 8 citations and provides a critical framework for improving the dismal 70% adult survival rate toward the 90% seen in pediatric cases. Beyond rare tumors, Basso has made substantial contributions to prostate cancer care. Through the MIRROR-SIU/LUNA and Pros-IT CNR studies, he analyzed over 1,500 patients to document how radical prostatectomy techniques have evolved over the past decade in Italy, offering real-world insights into surgical trends. His work stands at the intersection of advanced robotics, evidence-based oncology, and the pursuit of better outcomes for patients with the most challenging diagnoses.
Research Focus
Key Achievements
Top Papers
- 1
- 2